(Q24244197)

title

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

5

J C Craig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

4

S D Navaneethan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

author name string

C Bonifati

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

M Craig

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

18 October 2006

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

page(s)

CD006257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Appropriate Blood Pressure Control in NIDDM (ABCD) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: a one-year randomized study of valsartan versus enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Microalbuminuria and ACE inhibition in non-hypertensive diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Review: intensive blood pressure control and drugs reduce morbidity and mortality in hypertension and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Antihypertensive agents for preventing diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006257

Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group

21 January 2018

1 reference

12 December 2020

Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study

1 reference

12 December 2020

Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria

1 reference

12 December 2020

Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: comparative effects of angiotensin-converting enzyme inhibitors and β-adrenoceptor blockers

1 reference

12 December 2020

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

12 December 2020

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

12 December 2020

Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial

1 reference

12 December 2020

Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Prognosis of diabetic patients post-MI: the role of ACE inhibitor treatment. GISSI-3 Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico

1 reference

12 December 2020

Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study

1 reference

12 December 2020

Drug treatment for hypertensive patients in special situations: diabetes and hypertension

1 reference

12 December 2020

Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.

1 reference

12 December 2020

Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in ID

1 reference

12 December 2020

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes

1 reference

12 December 2020

Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: a 3-year placebo-controlled biopsy study

1 reference

12 December 2020

Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.

1 reference

12 December 2020

The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature

1 reference

12 December 2020

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

1 reference

12 December 2020

Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group

1 reference

12 December 2020

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

12 December 2020

Diabetic microalbuminuria and cilazapril

1 reference

12 December 2020

Possible effect of angiotensin-converting enzyme inhibition on glomerular charge selectivity

1 reference

12 December 2020

Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy

1 reference

12 December 2020

Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients

1 reference

12 December 2020

Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two-year trial

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT)

1 reference

12 December 2020

Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors

1 reference

12 December 2020

Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria

1 reference

12 December 2020

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

12 December 2020

Treatment of hypertension in adults with diabetes

1 reference

12 December 2020

Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial

1 reference

12 December 2020

The effects of a low-dose regimen of fosinopril on elevated urinary albumin excretion in normotensive type 1 diabetic patients

1 reference

12 December 2020

Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial

1 reference

12 December 2020

10.1002/14651858.CD006257

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3620255

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

3620255

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956646&resulttype=core&format=json

13 May 2020

PubMed publication ID

17054288

2 references

Consolidated OpenCitations Corpus – April 2017

3620255